C3 Glomerulopathy C3g clinical trials

Explore recruiting c3 glomerulopathy c3g clinical trials.

Recruiting c3 glomerulopathy c3g studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

C3 Glomerulopathy C3g trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients with C3-Glomerulopathy

Austria, Greece, Spain, Czechia, Latvia, Belgium +5 more

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Real-World Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy (C3G) or Primary Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN): A Multi-Country Study (PRISMC3)

France, Italy, Spain, Germany

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2 Proof of Concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of OMS906 in Patients with C3 Glomerulopathy (C3G) and Idiopathic Immune Complex-Mediated Glomerulonephritis (ICGN)

Lithuania, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis (VALE)

Spain, Italy, Czechia, France, Netherlands, Belgium +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

C3 Glomerulopathy C3g trials by city

C3 Glomerulopathy C3g in Toronto C3 Glomerulopathy C3g in Vancouver C3 Glomerulopathy C3g in Montreal C3 Glomerulopathy C3g in Calgary C3 Glomerulopathy C3g in Edmonton C3 Glomerulopathy C3g in Ottawa C3 Glomerulopathy C3g in Winnipeg C3 Glomerulopathy C3g in Quebec City C3 Glomerulopathy C3g in Hamilton C3 Glomerulopathy C3g in Kitchener C3 Glomerulopathy C3g in London C3 Glomerulopathy C3g in Halifax C3 Glomerulopathy C3g in New York C3 Glomerulopathy C3g in Los Angeles C3 Glomerulopathy C3g in Chicago C3 Glomerulopathy C3g in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease